“…This supportive metastatic microenvironment in distant organs was first termed the pre-metastatic niche (PMN) by Kaplan et al (2005) . In the last decade, PMN induced by various cancers has been identified in the lung ( Hiratsuka et al, 2002 ; Hoshino et al, 2015 ; Liu et al, 2016 ; Tyagi et al, 2021 ), liver ( Hoshino et al, 2015 ; Zhang and Wang, 2015 ; Houg and Bijlsma, 2018 ; Sun et al, 2021 ), brain ( You et al, 2020 ), bone ( Kaplan et al, 2007 ; Xu et al, 2017 ), and other organs. The PMN is characterized by increased vascular permeability ( Gupta et al, 2007 ; Huang et al, 2009 ; Zhou et al, 2014 ), a modified extracellular matrix (ECM) ( Aguado et al, 2016 ; Kim et al, 2019 ; Mohan et al, 2020 ), recruited bone marrow-derived cells (BMDCs) ( Kitamura et al, 2015 ; Wang et al, 2019 ), and immunosuppression ( Chen et al, 2011 ; Tacke et al, 2012 ; Giles et al, 2016 ) in the future metastatic organs.…”